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Quantitative determinations of U. urealyticum and M. hominis have been performed in 164
men with non-gonococcal urethritis (NGU) and 597 patients with chronic prostatitis. Evidence
is provided that U. urealyticum plays an etiologic role in 29.3 percent of patients with non-
gonococcal urethritis. Mixed infections of C. trachomatis and U. urealyticum, in high
numbers, do occur in 11 percent of NGU cases. A constellation suggesting ureaplasma-
associated disease could be observed in 13.7 to 15.2 percent of 597 patients with chronic pros-
tatitis. M. hominis does not appear to be a causative agent of NGU or chronic prostatitis.
INTRODUCTION
Non-gonococcal urethritis (NGU) appears to be the most frequent sexually
transmitted disease in industrialized countries [1,2,3]. Approximately 50 percent of
NGU cases are caused by Chlamydia trachomatis (3]. In addition, it has been well
established that Ureaplasma urealyticum is another etiologic agent of NGU [3,4].
But, in an individual man with chlamydia-negative urethritis, it has been difficult to
demonstrate that U. urealyticum is the causative pathogen, because up to 70 percent
of healthy persons harbor the organisms in their urethra [3,4,5]. Titer rises of serum
antibodies in NGU patients have not been demonstrated so far, either because ofthe
insufficient sensitivity of the methods employed or because of the superficial nature
of the infection, which does not induce high levels of systemic antibodies. In a dif-
ferent approach, we have therefore used quantitative procedures to establish the
possibility of U. urealyticum as the etiologic agent in individual patients with NGU
and thus determine the role of the organisms as a primary pathogen in this disease.
The etiology of chronic prostatitis is by far more obscure than that of NGU [6].
Common pathogens of the urogenital tract can only be found with low frequency
(< 10 percent) in patients with chronic prostatitis. Because U. urealyticum can cause
urethritis, the possibility arises that the organisms also induce ascending inflam-
matory reactions ofthe prostate. Since the technique of Meares and Stamey has suc-
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All rights of reproduction in any form reserved.cessfully been used to localize infections of the male genital tract with common
bacteria, we have employed this procedure, together with quantitative culture
techniques, for common bacteria, candida species, U. urealyticum, and Myco-
plasma hominis in order to unravel the role ofthe latter two species in chronic pros-
tatitis [7]. This publication summarizes data on 164 patients with NGU and 597 men
with chronic prostatitis [8,9].
STUDY POPULATION AND METHODS
Study Population
One hundred and sixty-four patients (mean age, 34 years), attending the outpa-
tient clinic of the Department of Urology, University of Giessen, from January 1,
1979, until December 31, 1980, were studied. All men complained of spontaneous
urethral discharge. The presence of Neisseria gonorrhoeae was excluded by gram
stain and inoculation of discharge on Thayer-Martin agar.
In addition, 597 men with chronic prostatitis were examined during the period of
1975-1980. Patients with prostatitis typically complained ofvariable symptoms, like
urinary frequency, urgency, nocturia, terminal dysuria, abdominal aching,
backache, and testicular, penile, or perineal pain. In a few asymptomatic men pros-
tatic tenderness or edema at rectal examination were the reasons for further
diagnostic procedures. Thirty-two (5.4 percent) of these patients (mean age, 41
years) had chronic bacterial prostatitis with common urinary tract pathogens,
predominantly Escherichia coli. Prostatodynia was the diagnosis in 187 men (31.3
percent) (mean age, 39 years). In 82 patients (mean age, 42 years) ureaplasma-
associated prostatitis was suggested by quantitative culture criteria as detailed in
results. In 296 men (49.6 percent) the etiology of the disease remained obscure. Men
with upper urinary tract infection by known pathogens and patients who had taken
antibiotics within four weeks before attendance were excluded from the study.
Forty-eight men (mean age, 42.5 years) without inflammatory response of the
urogenital tract were studied as controls. In addition, uroflowmetry was used for
detection of obstructive disorders as a cause of recurrent infections.
Microbiological Procedures (Table 1)
In men with NGU, 0.01 ml of urethral discharge was taken with a bacteriological
loop from the meatus urethrae and transferred to a transport medium [10]. In addi-
tion, fluor urethrae was inoculated into cycloheximide-treated McCoy cells for the
cultivation of chlamydiae [11]. For isolation of ureaplasmas and mycoplasmas, 0.1
ml of the transport medium and 0.1 ml of first-voided urine were inoculated on
A-6D agar, later A-7 agar, and into U-9 broth [12,13]. For cultivation ofM. hominis
a standard mycoplasma agar and broth were also inoculated. These two media were
later omitted, when it was found that M. hominis could be isolated with the same ef-
ficiency on A-6-D, resp. A-7, agar and U-9 broth. After incubation of agar plates
for five days under anaerobic conditions (Gas-Pak-System, Becton-Dickinson,
Heidelberg, FRG) colonies were counted, using a dissecting microscope at a
magnification of 25 x. The U-9 broth was observed twice daily for a color change
of the pH indicator. When the indicator started to change color, subcultivation was
performed immediately on agar plates. If a color change was not seen after five
days, the tubes were discarded. Ureaplasmas were identified by their characteristic
colony morphology and by their resistance to lincomycin. M. hominis was identified
by epi-immunofluorescence. Details of the procedures have been described previ-
ously [8-10].
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TABLE I
Diagnostic Schedules in Urethritis (164 men), Chronic Prostatitis (597 patients),
and 48 Healthy Volunteers
Prostatitis and
Urethritis Controls
Urethral Discharge VB,:
Quantitative culture for mycoplasmas Quantitative culture for common bacteria,
Gram stain and culture for: mycoplasmas, and fungi
Neisseria gonorrhoeae VB2:
Culture for: as VB, and sediment: leucocytes
C. trachomatis
EPS:
VB,: as VB,; Gram stain and culture for
Quantitative culture for common bacteria, N. gonorrhoeae, culture for
mycoplasmas, and fungi C. trachomatis
and microscopy + culture for T. vaginalis VB3:
sediment: leucocytes V3 as VB,; microscopy and culture for
T. vaginalis sediment: leucocytes
In patients with prostatitis and in healthy controls, 10 ml of first-voided urine
(VB,), midstream urine (VB2), expressed prostatic secretions (EPS), and 10 ml of
first-voided urine after massage (VB3) were obtained [7]. This procedure, proposed
by Meares and Stamey, has proved to be very useful in localization of the infection.
If midstream urine (VB2) is sterile or contains very low numbers of bacteria and
first-voided urine (VB,) exhibits at least tenfold higher numbers of bacteria than
EPS and VB3, the infection is localized to the urethra (urethritis). In bacterial pros-
tatitis, the number of CFU in EPS and usually also in VB3 exceeds by at least one
logarithm the number of CFU in VBR. If VB2 contains significant numbers of
bacteria (105 CFU or more) the infection cannot be localized to the urethra or the
prostate and is therefore considered as upper urinary tract infection.
Common urinary tract pathogens were quantitated, according to standard tech-
niques. Quantitative culture of ureaplasmas and mycoplasmas in all four kinds of
specimens was as described above. C. trachomatis was cultured in EPS. In addition,
EPS was investigated by gram stain and culture on Thayer-Martin medium for the
presence of Neisseria gonorrhoeae. Microscopy and cultivation for Trichomonas
vaginalis was performed on VB3 (Table 1). Patients with positive results for N.
gonorrhoeae, C. trachomatis, or T. vaginalis have not been included in the study.
Leucocyte counts could not be performed on EPS, because all available material was
used for the microbiological procedures.
RESULTS
Non-Gonococcal Urethritis
As can be seen in Table 2, U. urealyticum could be isolated in numbers of more
than 104 colony-forming units (CFU) from urethral discharge and more than 103
CFU per ml from VB% in 48 (29.3 percent) of the 164 NGU patients. In six of these
48 patients, mixed infections with M. hominis, also in high numbers, were observed.
In 18 patients (11 percent) U. urealyticum in high numbers and C. trachomatis were
isolated, whereas C. trachomatis alone was seen in 59 (36 percent) of men with
NGU. Ten or more leucocytes per high-power field (400 x) of the sediment from
VBy were observed in 71.7 percent of chlamydia-positive, ureaplasma-negative men
and 47.6 percent of the 42 patients with high ureaplasma numbers. Furthermore, T.
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TABLE 2
Non-Gonococcal Urethritis
(n = 164)
Organisms Isolated No. of Men
U. urealyticuma 42 25.6
U. urealyticum, 6 3.7
+ M. hominis6
U. urealyticum" 18 11
+ C. trachomatis
C. trachomatis 59 36
T. vaginalis 3 1.8
a > 104 CFU/ml urethral discharge
> 103 CFU/ml VB, (voided bladder 1)
vaginalis was detected in three (1.8 percent) ofthe 164 men with NGU. The patients,
from whom C. trachomatis and high numbers of U. urealyticum had been isolated,
were treated with 500 mg of tetracycline-HCl twice daily for 14 days. All men were
cured two to three weeks after therapy.
Chronic Prostatitis
In 82 (13.7 percent) of the 597 patients with chronic prostatitis the typical pros-
tatitis histogram, described by Meares and Stamey [7], was observed for U.
urealyticum (Table 3). Eighty of these patients had high numbers of ureaplasmas in
EPS and 51 also in VB3 but low numbers or no ureaplasmas in VB1 and VB2. In the
remaining two patients, who had high ureaplasma numbers in VB1 and VB2, CFU in
TABLE 3
Prostatitis Constellation for U. urealyticum (82 men) and M. hominis (10 men) of 597 Patients Studied
with the Chronic Form of the Disease, in Accordance with the Proposal by Meares and Stamey
for Localization of the Infection
Specimens from Which Indicated
No. of Organisms Were Isolated No. of Men 0/
U. urealyticum
VB,: >103 CFU/ml 2 0.3
VB2: >103 CFU/ml 1 0.2
EPS: > 103 CFU/ml 82 13.7
VB3: > 103 CFU/ml 51 8.5
M. hominis
VB,: > 103 CFU/ml 0 0
VB2: >103 CFU/ml 0 0
EPS: >103 CFU/ml 10" 1.7
VB3: >103 CFU/ml 3u 0.5
,,Mixed infections with U. urealyticum (seven patients), E. coli (two patients) or S. faecalis (one man)
CFU, colony-forming units
VB%, first-voided urine
VB2, midstream urine
EPS, expressed prostatic secretions
VB3, urine voided after prostatic massage
Prostatitis, high numbers of CFU in VB3 and/or EPS, low numbers in VB, and VB2UREAPLASMAS IN NGU AND CHRONIC PROSTATITIS
VB, and VB2 were more than tenfold lower than in EPS, which was still in accor-
dance with a prostatitis histogram. In an additional nine patients, high numbers of
ureaplasmas were observed in VB1, VB2 (eight patients), and EPS (data not shown).
In these men a significant difference in the number of organisms between VB, resp.
VB2 and EPS was not seen, indicating most probably prostato-urethritis. If these
nine are added to the previous group of 82 men, a total of 91 (15.2 percent) of the
patients may be considered to suffer from ureaplasma-associated chronic prostatitis.
The 82 men with ureaplasma-associated prostatitis were treated with 500 mg of
tetracycline-HCl twice daily for 14 days. Seventy-one of these patients were cured 21
to 28 days after start of treatment, and ureaplasmas were no longer detected. Seven
of the remaining eleven men had bladder neck obstruction. In four men no obvious
explanation for the therapy failure could be found.
M. hominis was cultured from ten men in the typical prostatitis configuration, but
always in mixed infections with high numbers of either U. urealyticum (seven men),
Escherichia coli (two), or Streptococcusfaecalis (one), who also showed a prostatitis
pattern (Table 3). In an additional 12 patients, from whom M. hominis could be
isolated in high numbers, a prostatitis histogram was not seen (data not shown).
Eleven of these men had more than 103 CFU in VB1, midstream-urine, and EPS.
U. urealyticum was isolated from VB1 (eight men), VB2 (none), EPS (three men),
and VB3 (three men) ofthe 48 healthy persons but always in numbers below 103 CFU
per ml. M. hominis was cultured from VB1 (six men), VB2 (none), EPS (one man),
and VB3 (one man) of healthy volunteers. Although in one man more than 104 CFU
ofM. hominis per ml ofEPS and 103.' CFU per ml of VB3 were isolated, he did not
exhibit any symptoms or signs of lower genital tract disease.
In 32 (5.4 percent) of the 597 men, common urinary tract pathogens caused the
disease, whereas 187 (31.3 percent) patients suffered from prostatodynia. In the re-
maining patients variable results were obtained which did not permit an etiological
diagnosis.
DISCUSSION
Our studies on non-gonococcal urethritis have confirmed previous findings,
which indicated that approximately 45 to 50 percent of the NGU cases are caused by
C. trachomatis [1,2,3]. In addition, evidence was provided that in approximately 30
percent of the NGU patients U. urealyticum was the etiologic agent. As expected, in
11 percent of patients a mixed infection of C. trachomatis and high numbers of U.
urealyticum was observed. In these men the etiology remained obscure.
In previous studies on 312 patients with prostato-urethritis, it was demonstrated
that disease symptoms in men, who had high numbers of U. urealyticum inEPS and
VB3, disappeared after tetracycline treatment, and the mycoplasmas could not be re-
isolated, whereas in patients with high numbers of M. hominis disease symptoms
persisted, although mycoplasmas were no longer detected after therapy [14]. The
data indicated that U. urealyticum, but not M. hominis, was connected with disease.
In further studies, tetracycline therapy was therefore considered to be justified only
in patients with high numbers of U. urealyticum.
Ureaplasma-associated prostatitis was evident in 13.7 to 15.2 percent of men with
chronic prostatitis. Therapy failure in11 of these patients could be explained by
bladder neck obstruction, reinfection via the sexual partner, or by appearance of
tetracycline-resistant ureaplasmas [15]. In addition, infection with another
tetracycline-sensitive microorganism should be considered [161. The data do not
ultimately prove the etiologic importance of U. urealyticum in these men, but isola-
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tion and treatment results point in this direction. Further studies, using serum or
local antibody determinations and/or serotyping of isolates could provide addi-
tional evidence for the causative role of the organisms in chronic prostatitis.
For the etiological diagnosis of NGU we regard it as mandatory to include culture
procedures for C. trachomatis and quantitative (CFU) determinations of U.
urealyticum. In chronic prostatitis, the localization technique ofMeares and Stamey
can now be recommended for the diagnosis of ureaplasma infection similar to its
previous use for prostatitis caused by common bacteria.
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